266 related articles for article (PubMed ID: 27807722)
1. Metabolomics in pancreatic cancer biomarkers research.
Tumas J; Kvederaviciute K; Petrulionis M; Kurlinkus B; Rimkus A; Sakalauskaite G; Cicenas J; Sileikis A
Med Oncol; 2016 Dec; 33(12):133. PubMed ID: 27807722
[TBL] [Abstract][Full Text] [Related]
2. [Gastroenterological Cancer Diagnosis by Metabolomics-Discovery of Pancreatic Cancer Biomarker].
Yoshida M; Nishiumi S; Azuma T
Rinsho Byori; 2015 Apr; 63(4):450-6. PubMed ID: 26536778
[TBL] [Abstract][Full Text] [Related]
3. A systematic review on metabolomics-based diagnostic biomarker discovery and validation in pancreatic cancer.
Long NP; Yoon SJ; Anh NH; Nghi TD; Lim DK; Hong YJ; Hong SS; Kwon SW
Metabolomics; 2018 Aug; 14(8):109. PubMed ID: 30830397
[TBL] [Abstract][Full Text] [Related]
4. Metabolomic profile in pancreatic cancer patients: a consensus-based approach to identify highly discriminating metabolites.
Di Gangi IM; Mazza T; Fontana A; Copetti M; Fusilli C; Ippolito A; Mattivi F; Latiano A; Andriulli A; Vrhovsek U; Pazienza V
Oncotarget; 2016 Feb; 7(5):5815-29. PubMed ID: 26735340
[TBL] [Abstract][Full Text] [Related]
5. Metabolomics approaches in pancreatic adenocarcinoma: tumor metabolism profiling predicts clinical outcome of patients.
Battini S; Faitot F; Imperiale A; Cicek AE; Heimburger C; Averous G; Bachellier P; Namer IJ
BMC Med; 2017 Mar; 15(1):56. PubMed ID: 28298227
[TBL] [Abstract][Full Text] [Related]
6. Metabolomics identified new biomarkers for the precise diagnosis of pancreatic cancer and associated tissue metastasis.
Luo X; Liu J; Wang H; Lu H
Pharmacol Res; 2020 Jun; 156():104805. PubMed ID: 32278036
[TBL] [Abstract][Full Text] [Related]
7. Metabolomics workflow for lung cancer: Discovery of biomarkers.
Tang Y; Li Z; Lazar L; Fang Z; Tang C; Zhao J
Clin Chim Acta; 2019 Aug; 495():436-445. PubMed ID: 31103622
[TBL] [Abstract][Full Text] [Related]
8. Urinary Metabolic Biomarkers in Cancer Patients: An Overview.
De Matteis S; Bonafè M; Giudetti AM
Methods Mol Biol; 2021; 2292():203-212. PubMed ID: 33651364
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parameters.
Urayama S
World J Gastroenterol; 2015 Feb; 21(6):1707-17. PubMed ID: 25684935
[TBL] [Abstract][Full Text] [Related]
10. Gastric cancer: Metabolic and metabolomics perspectives (Review).
Xiao S; Zhou L
Int J Oncol; 2017 Jul; 51(1):5-17. PubMed ID: 28535006
[TBL] [Abstract][Full Text] [Related]
11. Metabolomics approaches and applications in prostate cancer research.
Zhang A; Yan G; Han Y; Wang X
Appl Biochem Biotechnol; 2014 Sep; 174(1):6-12. PubMed ID: 24838846
[TBL] [Abstract][Full Text] [Related]
12. Discovery of urine biomarkers for bladder cancer via global metabolomics.
Shi H; Li X; Zhang Q; Yang H; Zhang X
Biomarkers; 2016 Nov; 21(7):578-88. PubMed ID: 27133288
[TBL] [Abstract][Full Text] [Related]
13. Identification of highly sensitive biomarkers that can aid the early detection of pancreatic cancer using GC/MS/MS-based targeted metabolomics.
Hirata Y; Kobayashi T; Nishiumi S; Yamanaka K; Nakagawa T; Fujigaki S; Iemoto T; Kobayashi M; Okusaka T; Nakamori S; Shimahara M; Ueno T; Tsuchida A; Sata N; Ioka T; Yasunami Y; Kosuge T; Kaneda T; Kato T; Yagihara K; Fujita S; Yamada T; Honda K; Azuma T; Yoshida M
Clin Chim Acta; 2017 May; 468():98-104. PubMed ID: 28215548
[TBL] [Abstract][Full Text] [Related]
14. In Situ Metabolomics in Cancer by Mass Spectrometry Imaging.
Buck A; Aichler M; Huber K; Walch A
Adv Cancer Res; 2017; 134():117-132. PubMed ID: 28110648
[TBL] [Abstract][Full Text] [Related]
15. Metabolomics: a revolution for novel cancer marker identification.
Bu Q; Huang Y; Yan G; Cen X; Zhao YL
Comb Chem High Throughput Screen; 2012 Mar; 15(3):266-75. PubMed ID: 22221059
[TBL] [Abstract][Full Text] [Related]
16. Metabolomics for mitochondrial and cancer studies.
Nagrath D; Caneba C; Karedath T; Bellance N
Biochim Biophys Acta; 2011 Jun; 1807(6):650-63. PubMed ID: 21420931
[TBL] [Abstract][Full Text] [Related]
17. A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women.
Jiao L; Maity S; Coarfa C; Rajapakshe K; Chen L; Jin F; Putluri V; Tinker LF; Mo Q; Chen F; Sen S; Sangi-Hyghpeykar H; El-Serag HB; Putluri N
Cancer Prev Res (Phila); 2019 Apr; 12(4):237-246. PubMed ID: 30723176
[TBL] [Abstract][Full Text] [Related]
18. Serum Metabolomic Profiles for Human Pancreatic Cancer Discrimination.
Itoi T; Sugimoto M; Umeda J; Sofuni A; Tsuchiya T; Tsuji S; Tanaka R; Tonozuka R; Honjo M; Moriyasu F; Kasuya K; Nagakawa Y; Abe Y; Takano K; Kawachi S; Shimazu M; Soga T; Tomita M; Sunamura M
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28375170
[TBL] [Abstract][Full Text] [Related]
19. [Possibility of Metabolite Biomarkers for Early Detection of Cancer].
Nishiumi S; Yoshida M
Gan To Kagaku Ryoho; 2018 Jun; 45(6):894-898. PubMed ID: 30026409
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
